Patents by Inventor Ravi Jasuja

Ravi Jasuja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220206018
    Abstract: The technology described herein is directed to the diagnosis and treatment of sex hormone disorders and/or deficiencies, such as estrogen and/or testosterone disorders and/or deficiencies.
    Type: Application
    Filed: October 8, 2021
    Publication date: June 30, 2022
    Applicant: Function Promoting Therapies LLC
    Inventors: Ravi Jasuja, Shalender Bhasin
  • Publication number: 20200174026
    Abstract: The technology described herein is directed to the diagnosis and treatment of androgen disorders and/or deficiencies, e.g. low testosterone.
    Type: Application
    Filed: July 3, 2019
    Publication date: June 4, 2020
    Applicant: Function Promoting Therapies LLC
    Inventors: Ravi Jasuja, Shalender Bhasin, Mikhail N. Zakharov
  • Patent number: 10386375
    Abstract: The technology described herein is directed to the diagnosis and treatment of androgen disorders and/or deficiencies, e.g. low testosterone.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: August 20, 2019
    Assignee: Function Promoting Therapies LLC
    Inventors: Ravi Jasuja, Shalender Bhasin, Mikhail N. Zakharov
  • Publication number: 20160018420
    Abstract: The technology described herein is directed to the diagnosis and treatment of androgen disorders and/or deficiencies, e.g. low testosterone.
    Type: Application
    Filed: March 4, 2014
    Publication date: January 21, 2016
    Applicant: FUNCTION PROMOTING THERAPIES, LLC
    Inventors: Ravi Jasuja, Shalender Bhasin, Mikhail N. Zakharov
  • Publication number: 20130178454
    Abstract: The present invention is generally directed to a method of increasing testosterone levels in a subject comprising; administration of testosterone or analogue thereof along with an ornithine decarboxylase (ODC) inhibitor. The method selectively promotes beneficial effects of testosterone, while preventing side effects associated with testosterone administration. The present invention also directed to pharmaceutical composition and kits comprising testosterone or analogue thereof; ornithine decarboxylase inhibitors. The composition selectively promotes beneficial effects of testosterone, while preventing side effects of testosterone administration. In some embodiments, the present invention relates to a method of treatment of low testosterone levels in a subject by administrating testosterone and ODC inhibitor while preventing side effects associated with testosterone administration.
    Type: Application
    Filed: November 16, 2012
    Publication date: July 11, 2013
    Inventors: Shalender Bhasin, Ravi Jasuja